Your browser doesn't support javascript.
Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients.
Harberts, Aenne; Schaub, Golda M; Ruether, Darius F; Duengelhoef, Paul M; Brehm, Thomas T; Karsten, Hendrik; Fathi, Anahita; Jahnke-Triankowski, Jacqueline; Fischer, Lutz; Addo, Marylyn M; Haag, Friedrich; Luetgehetmann, Marc; Lohse, Ansgar W; Schulze Zur Wiesch, Julian; Sterneck, Martina.
  • Harberts A; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Schaub GM; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Germany.
  • Ruether DF; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Duengelhoef PM; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Brehm TT; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Germany.
  • Karsten H; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Fathi A; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Germany; Bernhard-Nocht-Institute for Tropical Medicine, Department for Clinical Immunology of Infectious Diseases,
  • Jahnke-Triankowski J; Department of Visceral Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; University Transplant Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Fischer L; Department of Visceral Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; University Transplant Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Addo MM; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Germany; Bernhard-Nocht-Institute for Tropical Medicine, Department for Clinical Immunology of Infectious Diseases,
  • Haag F; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Luetgehetmann M; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Germany; Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Lohse AW; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Germany.
  • Schulze Zur Wiesch J; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Germany. Electronic address: j.schulze-zur-wiesch@uke.de.
  • Sterneck M; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; University Transplant Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Clin Gastroenterol Hepatol ; 20(11): 2558-2566.e5, 2022 11.
Article in English | MEDLINE | ID: covidwho-1936142
ABSTRACT
BACKGROUND &

AIMS:

Liver transplant recipients (LTRs) show a decreased immune response after 2 severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) vaccinations compared with healthy controls (HCs). Here, we investigated the immunogenicity of additional vaccinations.

METHODS:

In this prospective study, humoral (anti-SARS-CoV-2 receptor-binding domain [anti-S RBD]) and cellular (interferon-gamma release assay) immune responses were determined after mRNA-based SARS-CoV-2 vaccination in 106 LTRs after a third vaccination and in 36 LTRs after a fourth vaccination. Patients with anti-S RBD antibody levels >0.8 arbitrary unit (AU)/mL after vaccination were defined as responders.

RESULTS:

After 3 vaccinations, 92% (97/106) of LTRs compared with 100% (28/28) of HCs were responders. However, the antibody titer of LTRs was lower compared with HCs (1891.0 vs 21,857.0 AU/mL; P < .001). Between a second and third vaccination (n = 75), the median antibody level increased 67-fold in LTRs. In patients seronegative after 2 vaccinations, a third dose induced seroconversion in 76% (19/25), whereas all HCs were already seropositive after 2 vaccinations. A spike-specific T-cell response was detected in 72% (28/39) after a third vaccination compared with 32% (11/34) after a second vaccination. Independent risk factors for a low antibody response (anti-S RBD <100 AU/mL) were first vaccination within the first year after liver transplant (odds ratio [OR], 8.00; P = .023), estimated glomular filtration rate <45 mL/min (OR, 4.72; P = .006), and low lymphocyte counts (OR, 5.02; P = .008). A fourth vaccination induced a 9-fold increase in the median antibody level and seroconversion in 60% (3/5) of previous non-responders.

CONCLUSIONS:

A third and fourth SARS-CoV-2 vaccination effectively increases the humoral and cellular immune response of LTRs, but to a lesser extent than in HCs. A fourth vaccination should be generally considered in LTRs.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Liver Transplantation / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Animals / Humans Language: English Journal: Clin Gastroenterol Hepatol Journal subject: Gastroenterology Year: 2022 Document Type: Article Affiliation country: J.cgh.2022.06.028

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Liver Transplantation / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Animals / Humans Language: English Journal: Clin Gastroenterol Hepatol Journal subject: Gastroenterology Year: 2022 Document Type: Article Affiliation country: J.cgh.2022.06.028